
| Pair Name | Vitamin C, GW841819X | ||
| Phytochemical Name | Vitamin C (PubChem CID: 54670067 ) | ||
| Anticancer drug Name | GW841819X (PubChem CID: / ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Vitamin C, GW841819X | |||
| Disease Info | [ICD-11: 2C30] | Melanoma | Investigative | |
| Gene Regulation | Down-regulation | Expression | HRH4 | hsa59340 |
| Down-regulation | Expression | HAT1 | hsa8520 | |
| Down-regulation | Expression | BRD4 | hsa23476 | |
| Down-regulation | Expression | H4C12 | hsa8362 | |
| In Vitro Model | A2058 | Amelanotic melanoma | Homo sapiens (Human) | CVCL_1059 |
| SK-MEL-28 | Cutaneous melanoma | Homo sapiens (Human) | CVCL_0526 | |
| SK-MEL-2 | Melanoma | Homo sapiens (Human) | CVCL_0069 | |
| C8161 | Cutaneous melanoma | Homo sapiens (Human) | CVCL_6813 | |
| 1205Lu | Cutaneous melanoma | Homo sapiens (Human) | CVCL_5239 | |
| In Vivo Model | Mice were then engrafted on the neck by injecting 2×10⁵ mouse melanoma cells, B16-F10, to produce experimental tumor. | |||
| Result | This study shows that ascorbate can enhance the efficacy of BET inhibitors, providing a possible clinical solution to challenges arising in phase I trials from the dose-dependent side effects of this class of epigenetic therapy. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Vitamin C Sensitizes Melanoma to BET Inhibitors. Cancer Res. 2018 Jan 15;78(2):572-583. doi: 10.1158/0008-5472.CAN-17-2040. | Click |